The involvement of sigma1 receptors in donepezil-induced rescue of hippocampal LTP impaired by beta-amyloid peptide

Brain Research Bulletin

Volumn 106, Issue , 2014, Pages 56-61

  Solntseva, E I ^a   Kapai, N A ^a   Popova, O V ^a   Rogozin, P D ^a   Skrebitsky, V G ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Beta amyloid peptide; Donepezil; Haloperidol; Hippocampal LTP; PRE 084; Sigma1 receptor

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; AMYLOID BETA PROTEIN; DONEPEZIL; HALOPERIDOL; SIGMA 1 OPIATE RECEPTOR; 2-(4-MORPHOLINO)ETHYL-1-PHENYLCYCLOHEXANE-1-CARBOXYLATE; AMYLOID BETA-PROTEIN (1-42); CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; MORPHOLINE DERIVATIVE; PEPTIDE FRAGMENT; PIPERIDINE DERIVATIVE; SIGMA OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; MALE; NONHUMAN; POPULATION SPIKE; PRIORITY JOURNAL; RAT; SPIKE; TETANUS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; TOXICITY; WISTAR RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CA1 REGION, HIPPOCAMPAL; CHOLINESTERASE INHIBITORS; HALOPERIDOL; INDANS; LONG-TERM POTENTIATION; MALE; MORPHOLINES; PEPTIDE FRAGMENTS; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, SIGMA;

EID: 84903824154     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.06.002     Document Type: Article

References (44)

1. Abe K., Niikura Y., Fujimoto T., Akaishi T., Misawa M. Involvement of dopamine D2 receptors in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats. Neuropharmacology 2008, 55:1419-1424.
2. Chen L., Dai X.N., Sokabe M. Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 (sigma1) receptor: optical imaging study in rat hippocampal slices. Neuropharmacology 2006, 50:380-392.
3. Shen Q.S., Wei W.Z., Shimahara T., Xie C.W. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 2002, 77:354-371.
4. Collina S., Gaggeri R., Marra A., Bassi A., Negrinotti S., Negri F., Rossi D. Sigma receptor modulators: a patent review. Expert Opin. Ther. Pat. 2013, 23:597-613.
5. Coultrap S.J., Bayer K.U. CaMKII regulation in information processing and storage. Trends Neurosci. 2012, 35:607-618.
6. Creighton A.E., Wilczynski W. Influence of dopamine D2-type receptors on motor behaviors in the green tree frog Hyla cinerea. Physiol. Behav. 2014, 127:71-80.
7. Debanne D., Poo M.-M. Spike-timing dependent plasticity beyond synapse-pre- and post-synaptic plasticity of intrinsic neuronal excitability. Front. Syn. Neurosci. 2010, 2:21. 10.3389/fnsyn.2010.00021.
8. Ginani G.E., Tufik S., Bueno O.F., Pradella-Hallinan M., Rusted J., Pompéia S. Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning. J. Psychopharmacol. 2011, 25:1508-1516.
9. Hashimoto M., Kazui H., Matsumoto K., Nakano Y., Yasuda M., Mori E. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?. Am. J. Psychiatry 2005, 162:676-682.
10. Hayashi T., Su T.P. Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases. Subcell. Biochem. 2010, 51:381-398.
11. Hayashi T., Tsai S.Y., Mori T., Fujimoto M., Su T.P. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin. Ther. Targets 2011, 15:557-577.
12. Huang Y.Y., Kandel E.R. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:2446-2450.
13. 11C]SA4503. Int. J. Neuropsychopharmacol. 2009, 12:1127-1131.
14. Ishima T., Nishimura T., Iyo M., Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1656-1659.
15. Kapai N.A., Bukanova J.V., Solntseva E.I., Skrebitsky V.G. Donepezil in a narrow concentration range augments control and impaired by beta-amyloid peptide hippocampal LTP in NMDA-independent manner. Cell. Mol. Neurobiol. 2012, 32:219-226.
16. Kapay N.A., Popova O.V., Isaev N.K., Stelmashook E.V., Kondratenko R.V., Zorov D.B., Skrebitsky V.G., Skulachev V.P. Mitochondria-targeted plastoquinone antioxidant SkQ1 prevents amyloid-β-induced impairment of long-term potentiation in rat hippocampal slices. J. Alzheimers Dis. 2013, 36:377-383.
17. Kato K., Hayako H., Ishihara Y., Marui S., Iwane M., Miyamoto M. TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neurosci. Lett. 1999, 260:5-8.
18. Kimura M., Akasofu S., Ogura H., Sawada K. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons. Brain Res. 2005, 1047(1):72-84.
19. Kourrich S., Su T.P., Fujimoto M., Bonci A. The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci. 2012, 35:762-771.
20. Kroker K.S., Rast G., Giovannini R., Marti A., Dorner-Ciossek C., Rosenbrock H. Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Neuropharmacology 2012, 62:1964-1974.
21. Kroker K.S., Moreth J., Kussmaul L., Rast G., Rosenbrock H. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitor and selective neuronal nicotinic receptor agonists. Brain Res. Bull. 2013, 96:28-38.
22. Krug M., Chepkova A.N., Geyer C., Ott T. Aminergic blockade modulates long-term potentiation in the dentate gyrus of freely moving rats. Brain Res. Bull. 1983, 11:1-6.
23. Kume T., Sugimoto M., Takada Y., Yamaguchi T., Yonezawa A., Katsuki H., Sugimoto H., Akaike A. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons. Eur. J. Pharmacol. 2005, 527:77-85.
24. Kunitachi S., Fujita Y., Ishima T., Kohno M., Horio M., Tanibuchi Y., Shirayama Y., Iyo M., Hashimoto K. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Res. 2009, 1279:189-196.
25. Maurice T., Su T.P., Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998, 83:413-428.
26. Maurice T., Meunier J., Feng B., Ieni J., Monaghan D.T. Interaction with sigma(1) protein, but not N-methyl-d-aspartate receptor, is involved in the pharmacological activity of donepezil. J. Pharmacol. Exp. Ther. 2006, 317:606-614.
27. Meunier J., Ieni J., Maurice T. Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas. J. Pharmacol. Exp. Ther. 2006, 317:1307-1319.
28. Meunier J., Ieni J., Maurice T. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br. J. Pharmacol. 2006, 149:998-1012.
29. Min D., Mao X., Wu K., Cao Y., Guo F., Zhu S., Xie N., Wang L., Chen T., Shaw C., Cai J. Donepezil attenuates hippocampal neuronal damage and cognitive deficits after global cerebral ischemia in gerbils. Neurosci. Lett. 2012, 510:29-33.
30. Mucke L., Selkoe D.J. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2012, 2:a006338.
31. Nomura I., Kato N., Kita T., Takechi H. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci. Lett. 2005, 391:1-6.
32. Rammes G., Hasenjäger A., Sroka-Saidi K., Deussing J.M., Parsons C.G. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Neuropharmacology 2011, 60:982-990.
33. Reddy D.S., Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res. 1998, 791:108-116.
34. Relkin N.R. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease. Expert Rev. Neurother. 2007, 7:735-748.
35. Sabeti J., Nelson T.E., Purdy R.H., Gruol D.L. Steroid pregnenolone sulfate enhances NMDA-receptor-independent long-term potentiation at hippocampal CA1 synapses: role for L-type calcium channels and sigma-receptors. Hippocampus 2007, 17:349-369.
36. Solntseva E.I., Bukanova J.V., Skrebitsky V.G. Donepezil in low micromolar concentrations modulates voltage-gated potassium currents in pyramidal neurons of rat hippocampus. Biochem. Biophys. Res. Commun. 2013, 430:1066-1071.
37. Um J.W., Strittmatter S.M. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion 2013, 7:37-41.
38. van Waarde A., Ramakrishnan N.K., Rybczynska A.A., Elsinga P.H., Ishiwata K., Nijholt I.M., Luiten P.G., Dierckx R.A. The cholinergic system, sigma-1 receptors and cognition. Behav. Brain Res. 2011, 221:543-554.
39. Verney C., Baulac M., Berger B., Alvarez C., Vigny A., Helle K.B. Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience 1985, 14:1039-1052.
40. Wang H.Y., Stucky A., Liu J., Shen C., Trocme-Thibierge C., Morain P. Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain. J. Neurosci. 2009, 29:10961-10973.
41. Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 2004, 24:3370-3378.
42. Yang R., Chen L., Wang H., Xu B., Tomimoto H., Chen L. Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection. Neuropharmacology 2012, 63:1042-1050.
43. Ye L., Qiao J.T. Suppressive action produced by beta-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-d-aspartate receptor-independent: it's offset by (-)huperzine A. Neurosci. Lett. 1999, 275:187-190.
44. Yuan H., Wang W.P., Feng N., Wang L., Wang X.L. Donepezil attenuated oxygen-glucose deprivation insult by blocking Kv2.1 potassium channels. Eur. J. Pharmacol. 2011, 657:76-83.